And Roth values IMU at 71c / share. Coincidence? Probably. But here's the bit that's not a coincidence:
"Diamond Equity Research LLC is being compensated by Chimeric Therapeutics Limited for producingresearch materials regarding Chimeric Therapeutics Limited and its securities ..... As of 02/02/2023 the issuer had paid us $71,050 for our services, consisting of $20,000 for an initiationreport and $15,000 for update notes in the first year, and $36,050 for the following year of update notes,which commenced 09/03/2021 ..... The issuer has paid us for non-research related services as of 02/02/2023consisting of $5,500 for presenting at two virtual investment conferences."
I'm not aware of any broker coverage of a Hopper company that's not paid for by the company.
Used to wondered why broker firms weren't embarrassed by issuing ridiculous 71c valuations for sub-10c companies, but that's because I used to think that investors were the clients of the broker. Once you realise that its the company that's the client, it all makes sense.
CHM Price at posting:
6.9¢ Sentiment: None Disclosure: Not Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)